凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06821 凯莱英

已收盘 12-23 16:08:09

76.600

-1.300

-1.67%

最高80.500	最低76.550	成交量40.43万
今开79.300	昨收77.900	日振幅5.07%
总市值276.53亿	流通市值21.11亿	总股本3.61亿
成交额3,156万	换手率1.47%	流通股本2,755万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":76.6,"timestamp":1766477289007,"preClose":77.9,"halted":0,"volume":404300,"delay":0,"floatShares":27553260,"shares":361000000,"eps":2.982118838528014,"marketStatus":"已收盘","change":-1.3,"latestTime":"12-23 16:08:09","open":79.3,"high":80.5,"low":76.55,"amount":31563385,"amplitude":0.050706,"askPrice":76.6,"askSize":2500,"bidPrice":76.55,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":3.172366934482464,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766539800000},"marketStatusCode":5,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":77.9,"dividendRate":0.015885,"openAndCloseTimeList":[[1766453400000,1766462400000],[1766466000000,1766476800000]],"volumeRatio":1.692737,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":95.54,"timestamp":1766473200000,"preClose":94.7,"halted":0,"volume":3277700,"delay":0,"premium":"-27.68"}},"requestUrl":"/m/hq/s/06821","defaultTab":"news","newsList":[{"id":"2593023432","title":"股市必读：凯莱英（002821）12月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2593023432","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593023432?lang=zh_cn&edition=full","pubTime":"2025-12-23 02:56","pubTimestamp":1766429772,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘，凯莱英报收于94.7元，下跌0.09%，换手率1.24%，成交量3.93万手，成交额3.74亿元。董秘最新回复投资者： 尊敬的公司管理层：公司股价从高点回撤已30%有余，请问公司在维护市值方面有什么切实有效的措施？股票价格走势是波动变化的，受多种因素的综合影响，敬请广大投资者注意投资风险。交易信息汇总资金流向12月22日主力资金净流出274.28万元；游资资金净流入650.54万元；散户资金净流出376.27万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300001504.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1328615791.USD","06821","BK0132","BK1191","002821"],"gpt_icon":0},{"id":"2593710420","title":"港股异动 | CRO概念股承压走低 康龙化成(03759)跌超4% 昭衍新药(06127)跌超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593710420","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593710420?lang=zh_cn&edition=full","pubTime":"2025-12-22 15:24","pubTimestamp":1766388287,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股承压走低，截至发稿，康龙化成跌4.32%，报21.24港元；昭衍新药跌3.29%，报21.16港元；凯莱英跌2.31%，报78.15港元；维亚生物跌1.98%，报1.98港元。信达证券指，过去两年《生物安全法案》是压制CXO板块估值的重要原因，和最初版本相比，最终落地的版本没有点名具体企业，整体相对温和。虑到美联储已经进入降息通道，全球生物医药投融资有望边际改善，随着法案落地，CXO板块有望迎来业绩和估值的双重修复。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","06127","01873","603127","BK1191","BK0216","BK1576","300759","06821","03759"],"gpt_icon":0},{"id":"2592167370","title":"凯莱英(06821)将购回及注销3.3万股受限制A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2592167370","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592167370?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:30","pubTimestamp":1766151039,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，于2025年12月19日，本公司董事会审议并通过《关于回购注销2025年A股计划部分限制性股票的议案》，将购回及注销3.3万股由7名已离职合资格参与者根据2025年A股计划首次授予，以及一名已离职合资格参与者根据2025年A股计划预留授予项下所持有的已授出但尚未解禁的受限制A股股份(购回及注销事项)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383989.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","06821","002821","LU1328615791.USD","BK0239","399300","159982","BK1191"],"gpt_icon":0},{"id":"2592162940","title":"智通港股解盘 | 海南自贸港封关意义重大 无人驾驶利好密集催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2592162940","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592162940?lang=zh_cn&edition=full","pubTime":"2025-12-19 20:58","pubTimestamp":1766149121,"startTime":"0","endTime":"0","summary":"海南自由贸易港昨天正式启动全岛封关，8个对外开放口岸及10个“二线口岸”监管设施全部启用。标志着3万多平方公里的海南岛正式成为海关监管特殊区域，中国对外开放迎来具有里程碑意义的标志性举措。回购的H股股份将作为库存股持有，并在完成回购并披露回购结果公告后三年内完成转让或注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01801","BK1179","06821","LU0516423091.SGD","01318","02431","03759","01880","601995","BK1163","02039","02050","00699","BK1564","LU1719994722.HKD","LU2328871848.SGD","LU0307460666.USD","03908","BK1539","LU0819121731.USD","LU1880383366.USD","LU2039709279.SGD","01057","LU0417516902.SGD","01316","BK1500","LU0181495838.USD","06160","LU0348735423.USD","01999","02498","LU1794554557.SGD","02269","09868","BK1183","LU1969619763.USD","BK1589","LU0455707207.USD","BK1583","LU0348766576.USD","BK1224","LU1580142542.USD","09863","02533","SG9999002463.SGD","BK1191","BK1521","LU0593848301.USD"],"gpt_icon":1},{"id":"2592316870","title":"每日卖空追踪 | 凯莱英 12月19日卖空量成交1.04万股，卖空比例为2.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592316870","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592316870?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133036,"startTime":"0","endTime":"0","summary":"凯莱英北京时间12月19日，涨10.42%，卖空量成交1.04万股，较上一交易日增加285.19%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163628a45f3820&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163628a45f3820&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2592054168","title":"万亿级健康管理市场正加速启动，医疗ETF龙头半日涨1.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592054168","media":"财闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592054168?lang=zh_cn&edition=full","pubTime":"2025-12-19 12:29","pubTimestamp":1766118552,"startTime":"0","endTime":"0","summary":"消息面上，蚂蚁集团旗下AI健康应用“蚂蚁阿福”于12月15号发布后下载量猛增，于16日当天冲上苹果应用榜总榜第三位。数据显示，蚂蚁阿福55%的用户来自三线及以下城市，反映健康管理市场的供需缺口。“蚂蚁阿福”的增长印证了AI医疗从“概念”走向“实用”，万亿级健康管理市场正加速启动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219123247a6b56e9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219123247a6b56e9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2592345351","title":"医药股今早显著反弹 凯莱英及药明生物均涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592345351","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592345351?lang=zh_cn&edition=full","pubTime":"2025-12-19 11:05","pubTimestamp":1766113500,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　医药股今早明显反弹，CRO、创新药方向居前。截至发稿，凯莱英（06821）上涨6.07%，报76.85港元；药明生物（02269）上涨6.05%，报34.70港元；三生制药（01530）上涨4.65%，报26.58港元；诺诚健华（09969）上涨4.70%，报13.80港元。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-12-19/doc-inhcicep7752391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","SG9999002463.SGD","LU0417516902.SGD","LU0181495838.USD","LU0140636845.USD","LU0516422952.EUR","SG9999002562.SGD","LU0052750758.USD","LU0043850808.USD","LU1688375341.USD","BK1589","159938","LU0588546209.SGD","LU1328615791.USD","BK1161","BK0239","LU0456846285.SGD","06821","002821","LU1794554557.SGD","LU0359201612.USD","BK1521","LU0516423174.USD","LU0359202008.SGD","LU0572944931.SGD","BK1576","BK1610","BK1515","LU0348735423.USD","LU0417516738.SGD","LU0823426480.USD","LU0856984785.SGD","LU0327786744.USD","BK1141","LU1242518857.USD","LU0039217434.USD","LU0979878070.USD","LU1720050803.USD","02269","LU3063872942.SGD","LU0819121731.USD","LU0320764599.SGD","LU0516423091.SGD","LU0823426308.USD","IE00B0JY6N72.USD","LU0051755006.USD","09939","LU0708995583.HKD","LU0516422366.SGD","LU0456827905.SGD"],"gpt_icon":0},{"id":"2592139047","title":"医药外包概念普遍走高 药明生物(02269)涨6.11% 机构看好看好CXO在业绩和估值端迎来双重修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139047","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139047?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:26","pubTimestamp":1766111188,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念普遍走高，药明生物 涨6.11%，凯莱英升5.52%，康龙化成升4.69%，泰格医药升3.8%，维亚生物升3.72%，药明康德涨3.32%。世纪证券此前研报指出，本周NDAA法案落地，地缘风险趋于缓和。CXO业绩和新增订单开始好转，本周市场开始关注临床前安评试验资产食蟹猴。该机构认为CXO作为创新药产业链上游，行业经历过完整周期，有望受益于国产创新药竞争力提升带来的景气度回升，看好CXO在业绩和估值端迎来双重修复。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"66afc1ba6d0078bbc724c4259409298b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971871","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1589","LU0140636845.USD","LU2125910500.SGD","LU0456827905.SGD","03347","LU0516423091.SGD","LU3063872942.SGD","03759","BK1583","CXO","SG9999002562.SGD","LU0417516902.SGD","LU1242518931.SGD","LU0348735423.USD","LU0516422366.SGD","LU1720050803.USD","SG9999002463.SGD","LU0979878070.USD","IE00B0JY6N72.USD","LU0348825331.USD","LU1880383366.USD","02359","BK1574","LU0359201612.USD","LU0516423174.USD","09939","LU1794554557.SGD","01873","LU0516422952.EUR","LU0708995583.HKD","BK1610","06821","02269","LU0052750758.USD","LU0819121731.USD","LU0823426480.USD","LU0320764599.SGD","BK1521","LU0051755006.USD","LU2242644610.SGD","LU0039217434.USD","LU0181495838.USD","LU1046422090.SGD","LU0516422440.USD","LU2045819591.USD","BK1576","159938","LU0043850808.USD","BK1191"],"gpt_icon":0},{"id":"2592168082","title":"凯莱英盘中异动 早盘股价大涨5.18%报76.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592168082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592168082?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:04","pubTimestamp":1766109849,"startTime":"0","endTime":"0","summary":"2025年12月19日早盘10时04分，凯莱英股票出现异动，股价快速上涨5.18%。截至发稿，该股报76.200港元/股，成交量7.37万股，换手率0.27%，振幅4.83%。资金方面，该股资金流入346.344万港元，流出94.5905万港元。凯莱英股票所在的药品行业中，整体涨幅为0.36%。其相关个股中，凯莱英、三生制药、君圣泰医药-B涨幅较大，振幅较大的相关个股有三生制药、凯莱英、康臣药业，振幅分别为6.06%、4.62%、4.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121910040997a0797b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121910040997a0797b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2592949186","title":"每日卖空追踪 | 凯莱英 12月17日卖空量成交1200股，卖空比例为0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592949186","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592949186?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:30","pubTimestamp":1765960236,"startTime":"0","endTime":"0","summary":"凯莱英北京时间12月17日，跌0.89%，卖空量成交1200股，较上一交易日减少65.71%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163618a4561504&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163618a4561504&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2591402946","title":"每日卖空追踪 | 凯莱英 12月15日卖空量成交1900股，卖空比例为1.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591402946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591402946?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:30","pubTimestamp":1765787436,"startTime":"0","endTime":"0","summary":"凯莱英北京时间12月15日，跌3.37%，卖空量成交1900股，较上一交易日减少63.46%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163623a44d434f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163623a44d434f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2591657917","title":"医药行业周报：IN VIVO CART：BD热门赛道 早期技术具备广阔前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2591657917","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591657917?lang=zh_cn&edition=full","pubTime":"2025-12-14 00:00","pubTimestamp":1765641600,"startTime":"0","endTime":"0","summary":"核心观点：In Vivo CART赛道发展火热，2025年已经有四个MNC并购的案例发生。具体来看，In Vivo CART分为LNP和慢病毒两条技术路线，两条技术路线均具备显著特色。LNP路线来看，药物在临床前展现出了快速转染以及优异的靶向性特点，慢病毒路线中，Esobiotec等公司的BCMA In Vivo CART已经在小人群MM患者中展现非常好的早期数据。整体看，In VivoCART发展迅速，后续发展值得关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214150229a4496027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214150229a4496027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU1046422090.SGD","01177","BK1574","LU2242644610.SGD","BK1161","06160","01801","LU0052750758.USD","06978","LU0708995583.HKD","06821","BK1576","LU2125910500.SGD","LU2045819591.USD","BK1141","LU0320764599.SGD","02359"],"gpt_icon":0},{"id":"2591632904","title":"英伟达连续布局13家企业，AI制药3个方向梳理（附列表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2591632904","media":"投研大叔","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591632904?lang=zh_cn&edition=full","pubTime":"2025-12-13 19:40","pubTimestamp":1765626014,"startTime":"0","endTime":"0","summary":"今天介绍下AI制药，英伟达在过去2年投资13家AI药企，推出BioNeMo生物分子AI框架已经覆盖上百家药企，英硅智能ISM001-055进入临床III期，成为首个跨越临床II期的AI药物，从之前的布局到如今逐渐突破，商业价值正在逐渐被验证。从大叔个人来看，还有一些罕见病，由于患者少，研发不划算，而AI能快速低成本设计药物，让更多罕见病有药可治。近期热门文章HW组建医疗卫生军团，AI医疗爆发！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251213194757a4470c58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251213194757a4470c58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0308772762.SGD","LU1914381329.SGD","LU0157215616.USD","LU2065171311.SGD","06127","SGXZ81514606.USD","LU2860962120.EUR","NVDA","NVIW.SI","LU0320765059.SGD","LU0158827948.USD","LU0444973449.USD","NVD2.UK","NVDY","2NVD.UK","LU0096362180.USD","LU1280957306.USD","LU2505996509.AUD","LU2249611893.SGD","IE000YTNTUN2.SGD","NVDX","IE0034235188.USD","01093","LU2191332357.HKD","IE00BDCRKT87.USD","LU2463028550.USD","SNVD.UK","SG9999004303.SGD","LU2237438978.USD","NVD3.UK","LU1988902786.USD","IE000ITXATA3.USD","02359","IE00BJJMRY28.SGD","NVDS.UK","NVD","LU2473716301.USD","LU1839511570.USD","LU2602419157.SGD","NVDD","02228","LU1145028129.USD","LU1496350171.SGD","LU0719512351.SGD","NVDU","03759","LU2505996681.GBP","LU0274383776.USD","3NVD.UK","LU2592432038.USD","LU1642822529.SGD","06821","LU2420271590.USD","NVDS","02196","LU2089284900.SGD"],"gpt_icon":1},{"id":"2590850782","title":"每日卖空追踪 | 凯莱英 12月12日卖空量成交3800股，卖空比例为1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590850782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590850782?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:30","pubTimestamp":1765528234,"startTime":"0","endTime":"0","summary":"凯莱英北京时间12月12日，涨0.85%，卖空量成交3800股，较上一交易日减少70.54%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165432979e98c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165432979e98c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2590592453","title":"诺华领跑，药明康德狂飙！小核酸药物市场井喷，中国CDMO产业链迎来爆发式增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2590592453","media":"摩熵医药","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590592453?lang=zh_cn&edition=full","pubTime":"2025-12-11 10:26","pubTimestamp":1765419964,"startTime":"0","endTime":"0","summary":"2016年后，多款重磅小核酸药物陆续上市，在遗传罕见病和慢性病等领域取得重大突破，全球小核酸药物市场进入高速增长通道。近年来，中国小核酸领域的BD交易异常活跃。根据2025年中期报告，包含寡核苷酸、多肽等在内的化学大分子CDMO业务板块，收入达3.79亿元，同比增速超过130%。随着小核酸药物商业化的加速，国内CDMO企业迎来确定性的增长机遇。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211102610a4414f91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211102610a4414f91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02359","LU2242644610.SGD","LU0708995583.HKD","LU2045819591.USD","LU1046422090.SGD","LU0052750758.USD","LU0320764599.SGD","LU2125910500.SGD","BK1583","06821","BK1141","BK1576"],"gpt_icon":1},{"id":"2590303708","title":"重磅事件落地！商业化+出海提速，板块调整后弹性更突出","url":"https://stock-news.laohu8.com/highlight/detail?id=2590303708","media":"浙商证券融资融券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590303708?lang=zh_cn&edition=full","pubTime":"2025-12-10 13:02","pubTimestamp":1765342962,"startTime":"0","endTime":"0","summary":"关注研发实力强且已有商业化创新药产品上市的企业；CXO及生命科学上游产业链。CXO一体化龙头公司如药明康德，保持业绩持续向好趋势，业绩保持较快增长。投资者据此操作，风险自负。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512101335329534f1c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512101335329534f1c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06160","06821","BK1141","BK1574","LU1046422090.SGD","LU2045819591.USD","06978","02268","LU0052750758.USD","03759","BK1576","LU2125910500.SGD","02359","LU2242644610.SGD","BK1161","LU0708995583.HKD","LU0320764599.SGD","01801"],"gpt_icon":0},{"id":"2590309788","title":"每日卖空追踪 | 凯莱英 12月09日卖空量成交6900股，卖空比例为2.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590309788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590309788?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:30","pubTimestamp":1765269036,"startTime":"0","endTime":"0","summary":"凯莱英北京时间12月09日，跌0.44%，卖空量成交6900股，较上一交易日减少80.83%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209163607a43d412e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209163607a43d412e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2589233996","title":"ADC药物浪潮下，凯莱英、药明合联等CDMO企业产能角逐正酣","url":"https://stock-news.laohu8.com/highlight/detail?id=2589233996","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589233996?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:31","pubTimestamp":1765182717,"startTime":"0","endTime":"0","summary":"据悉，药明合联无锡基地目前抗体及偶联原液产能总产能约1.1万升，制剂总产能将计划在2027年扩展至3500万瓶。皓元医药ADC原液年产能可达1500kg，重庆抗体偶联CDMO基地配备1条抗体蛋白原液产线，年设计产能12万升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163650979615fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163650979615fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","SG9999014674.SGD","02268","BK1191","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2589354886","title":"每日卖空追踪 | 凯莱英 12月08日卖空量成交1.13万股，卖空比例为2.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589354886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589354886?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182635,"startTime":"0","endTime":"0","summary":"凯莱英北京时间12月08日，涨0.96%，卖空量成交1.13万股，较上一交易日减少25.17%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163601a72ab03e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163601a72ab03e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2589339958","title":"凯莱英12月08日主力净流入488.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2589339958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589339958?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:16","pubTimestamp":1765181761,"startTime":"0","endTime":"0","summary":"12月08日, 凯莱英股价涨0.96%，报收78.80元，成交金额3029.1万元，换手率1.38%，振幅5.57%，量比3.15。凯莱英今日主力资金净流入488.6万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.48%，主力资金累计净流入446.8万元；近20日主力资金累计净流出442.9万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208162232a72aa7a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208162232a72aa7a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.asymchem.com","stockEarnings":[{"period":"1week","weight":0.0435},{"period":"1month","weight":0.0237},{"period":"3month","weight":-0.18},{"period":"6month","weight":0.0701},{"period":"1year","weight":0.551},{"period":"ytd","weight":0.5389}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0231},{"period":"3month","weight":-0.0137},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3084},{"period":"ytd","weight":0.2862}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"凯莱英医药集团（天津）股份有限公司是一家主要从事提供医药外包一站式综合服务的中国公司。该公司的业务包括小分子药物定制研发生产（CDMO）、化学大分子CDMO、临床研究服务、制剂CDMO、生物大分子CDMO、技术输出和合成生物技术。该公司的产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司主要在国内外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.109047},{"month":2,"riseRate":0.5,"avgChangeRate":0.017674},{"month":3,"riseRate":0.25,"avgChangeRate":-0.034311},{"month":4,"riseRate":0.5,"avgChangeRate":-0.084779},{"month":5,"riseRate":0.5,"avgChangeRate":0.040294},{"month":6,"riseRate":0.5,"avgChangeRate":0.01751},{"month":7,"riseRate":0.5,"avgChangeRate":0.064856},{"month":8,"riseRate":0.25,"avgChangeRate":-0.064097},{"month":9,"riseRate":0.75,"avgChangeRate":0.16322},{"month":10,"riseRate":0,"avgChangeRate":-0.125554},{"month":11,"riseRate":0.5,"avgChangeRate":0.010602},{"month":12,"riseRate":0.25,"avgChangeRate":0.010892}],"exchange":"SEHK","name":"凯莱英","nameEN":"ASYMCHEM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,06821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}